Fractional exhaled nitric oxide levels and eosinophil counts after cessation of tezepelumab: Results from the PATHWAY phase 2b study

Fractional exhaled nitric oxide levels and eosinophil counts after cessation of tezepelumab: Results from the PATHWAY phase 2b study